Bayer CropScience Limited

NSE:BAYERCROP.NS

6399.35 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q1
Revenue 16,3129,8259,54916,17217,3969,82510,37914,51916,6748,0569,90113,65114,1596,1529,18213,81612,2783,6838,54013,4636,6364526,21011,0418,3183,0024,79712,3206,9802,1536,45110,8077,9924,4916,22211,49813,7135,4066,87212,15111,7245,2596,26610,2749,6633,6745,5918,0018,994.42,3604,8357,115.57,732.6
Cost of Revenue 11,0564,8135,28410,0919,9734,8135,9508,8038,5944,9045,6498,3597,8624,1925,4538,4746,4662,0344,6097,8003,3736873,6026,6383,9461,7142,8437,6173,8321,3194,3086,6044,2302,7924,0587,4829,8843,6334,4727,7608,2893,4183,9726,7016,8272,5123,6355,131.26,184.11,4182,9954,552.25,608.3
Gross Profit 5,2565,0124,2656,0817,4235,0124,4295,7168,0803,1524,2525,2926,2971,9603,7295,3425,8121,6493,9315,6633,263-2352,6084,4034,3721,2881,9544,7033,1488342,1434,2033,7621,6992,1644,0163,8291,7732,4004,3913,4351,8412,2943,5732,8361,1621,9562,869.82,810.39421,8402,563.32,124.3
Gross Profit Ratio 0.3220.510.4470.3760.4270.510.4270.3940.4850.3910.4290.3880.4450.3190.4060.3870.4730.4480.460.4210.492-0.520.420.3990.5260.4290.4070.3820.4510.3870.3320.3890.4710.3780.3480.3490.2790.3280.3490.3610.2930.350.3660.3480.2930.3160.350.3590.3120.3990.3810.360.275
Reseach & Development Expenses 06850008310007490005580005430005770002050002040001810002220002020001580000000
General & Administrative Expenses 0-1,092000-1,519000-1,3790001,0800001,0690001,6210008430008340006450007570005830005390000000
Selling & Marketing Expenses 02,4120003,1530003,0800001,9910001,9820002,1250001,5340001,5100001,6870001,5430002,8430002,3070000000
SG&A 2,3311,3201,8472,0242,2441,6341,4752,0502,8681,7011,4072,0732,0043,0719487699383,0518019138253,7468047317292,3776456406652,34461106142,3325265356802,3005374996584,6425494805523,866450449.500000
Other Expenses 2752961461612073,2251523,4894,3581,22298143148-358183147149-31119410272-229110981116329133163154211143193176126236258-571173277209-680234279231-41611576.76.6-2016659.113
Operating Expenses 2,3313,2253,1383,1483,4903,2253,7183,4894,3581,2223,7313,2173,2201,2942,8122,5042,7961,1852,4772,7752,1338602,2272,3012,1611,5391,8121,9072,0721,4961,7591,8961,9441,5571,7981,9352,4681,1581,7321,9992,0381,1271,9242,0671,7419681,4181,490.91,507.71,0081,3431,379.21,390.8
Operating Income 2,9251,7871,2733,0944,1401,9947112,3653,8641,9325212,2186196079172,9851,1004951,4542,9901,648-1,2513812,200491-1881422,929171-5083842,4505953183662,3174926936682,6698417283871,7856042235381,378.9653-1064971,184.1563
Operating Income Ratio 0.1790.1820.1330.1910.2380.2030.0690.1630.2320.240.0530.1620.0440.0990.10.2160.090.1340.170.2220.248-2.7680.0610.1990.059-0.0630.030.2380.024-0.2360.060.2270.0740.0710.0590.2020.0360.1280.0970.220.0720.1380.0620.1740.0630.0610.0960.1720.073-0.0450.1030.1660.073
Total Other Income Expenses Net 233165-31-37-79-421,125-75-41-37657-23559191144-25-39-238187-834-7-373-36-37-22-23-22-52-15192-17-19-2998-14-28-50164-8-9-15210-7-783911,28267.211,167-229-9957-165
Income Before Tax 3,1581,9521,2423,0574,0611,9521,8362,2903,8231,8951,1782,1953,2007981,0612,9603,1262571,6412,156919-1,2544542,1642,299-2101192,9071,222-5235762,4331,9932894642,3031,6116438322,6611,5997135971,7781,3201,06211,8201,446.11,305.1-3353981,241.1740.1
Income Before Tax Ratio 0.1940.1990.130.1890.2330.1990.1770.1580.2290.2350.1190.1610.2260.130.1160.2140.2550.070.1920.160.138-2.7740.0730.1960.276-0.070.0250.2360.175-0.2430.0890.2250.2490.0640.0750.20.1170.1190.1210.2190.1360.1360.0950.1730.1370.2892.1140.1810.145-0.1420.0820.1740.096
Income Tax Expense 6163673118287763674916647973683306546631791,512714609-58262458326-456179737827-81121,001105-162208842681951908025422092829005142512076134423442,786467.6417.7-119131400.6241.3
Net Income 2,5421,5859312,2293,2851,5851,3451,6263,0261,5278481,5412,537619-4512,2462,5173151,3791,698593-7982751,4271,472-1291071,9061,117-3613681,5911,3121942741,5011,0694345501,7611,0854623901,1658787189,034978.5887.4-216267840.5498.8
Net Income Ratio 0.1560.1610.0970.1380.1890.1610.130.1120.1810.190.0860.1130.1790.101-0.0490.1630.2050.0860.1610.1260.089-1.7650.0440.1290.177-0.0430.0220.1550.16-0.1680.0570.1470.1640.0430.0440.1310.0780.080.080.1450.0930.0880.0620.1130.0910.1951.6160.1220.099-0.0920.0550.1180.065
EPS 56.5635.2720.7249.673.0935.2729.9336.1867.3333.9818.8734.2956.4513.77-10.0349.9756.017.0130.6837.7830.11-17.778.0141.5642.87-3.763.125431.59-10.2110.414537.115.498.242.5530.29.6611.0348.1129.6410.2810.1429.4922.2315.97228.7224.7822.46-4.816.7621.2812.65
EPS Diluted 56.5635.2720.7249.673.0935.2729.9336.1867.3333.9818.8734.2956.4513.77-10.0349.9756.017.0130.6837.7830.11-17.758.0141.5642.87-3.763.125431.59-10.2110.414537.115.498.242.5530.29.6611.0348.1129.6410.2810.1429.4922.2315.97228.7224.7822.46-4.816.7621.2812.65
EBITDA 3,1401,1211,4253,2104,4532,2651,0062,5174,0932,1467612,3613,3718231,2433,1243,4026861,7973,1631,311-1,1655762,2842,409-1002553,0081,319-4276712,5172,0763815572,3761,6797549002,7171,6918357172,1281,4093197481,467.31,389.1-116461,266.5813.7
EBITDA Ratio 0.1920.1140.1490.1980.2560.2310.0970.1730.2450.2660.0770.1730.2380.1340.1350.2260.2770.1860.210.2350.198-2.5770.0930.2070.29-0.0330.0530.2440.189-0.1980.1040.2330.260.0850.090.2070.1220.1390.1310.2240.1440.1590.1140.2070.1460.0870.1340.1830.154-0.0050.1340.1780.105